| Q60435317 | Q60435317 |
| Q47709560 | A Multilevel Functional Study of a SNAP25 At-Risk Variant for Bipolar Disorder and Schizophrenia |
| Q47565189 | A latent class analysis of psychotic symptoms in the general population |
| Q41724432 | A self administered executive functions ecological questionnaire (the behavior rating inventory of executive function - adult version) shows impaired scores in a sample of patients with schizophrenia |
| Q51937346 | Admixture analysis of age at onset in schizophrenia. |
| Q57700318 | Analyse de la structure factorielle de la version brève du questionnaire de personnalité schizotypique (SPQ-B) – format Likert – en population générale en France |
| Q48022975 | Anhedonia in schizophrenia: a distinct familial subtype? |
| Q48328647 | Apolipoprotein E in schizophrenia: a French association study and meta-analysis. |
| Q38216116 | Association between cannabis use and schizotypal dimensions--a meta-analysis of cross-sectional studies |
| Q38143031 | Autoantibodies to neurotransmitter receptors and ion channels: from neuromuscular to neuropsychiatric disorders |
| Q34043769 | Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis |
| Q57700371 | Caractéristiques psychométriques de la version française de la signs and symptoms of psychotic illness scale (SSPI) |
| Q47717685 | Childhood trauma and psychosis: Beyond the association |
| Q104795222 | Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings |
| Q37412479 | Common variant at 16p11.2 conferring risk of psychosis. |
| Q57700313 | Comorbidity between schizophrenia and keratoconus |
| Q38385043 | Correlations between cognitive performances and psychotic or schizotypal dimensions. |
| Q34811849 | Different rates of first admissions for psychosis in migrant groups in Paris |
| Q43670728 | Environmental risk factors for schizophrenia: a review |
| Q57698047 | Executive deficits in psychotic and bipolar disorders – Implications for our understanding of schizoaffective disorder |
| Q57698076 | Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia |
| Q57700350 | Exploring the relationships between tobacco smoking and schizophrenia in first-degree relatives |
| Q36901257 | Expression and genetic variability of PCDH11Y, a gene specific to Homo sapiens and candidate for susceptibility to psychiatric disorders |
| Q40578078 | Familial aggregation of delusional proneness in schizophrenia and bipolar pedigrees |
| Q35914810 | Familial resemblance for executive functions in families of schizophrenic and bipolar patients |
| Q54604870 | Genetic and molecular exploration of UHMK1 in schizophrenic patients. |
| Q33762566 | Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations |
| Q33942632 | Influence of paternal age in schizophrenia |
| Q63869707 | Jumping To Conclusions, General Intelligence, And Psychosis Liability: Findings From The Multicentric EU-GEI Case-Control Study |
| Q37371852 | Lack of influence of COMT and NET genes variants on executive functions in schizophrenic and bipolar patients, their first-degree relatives and controls |
| Q34379248 | Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis. |
| Q37124266 | Longitudinal studies of cognition in schizophrenia: meta-analysis |
| Q45014217 | Maternal transmission disequilibrium of the glutamate receptor GRIK2 in schizophrenia. |
| Q30619862 | Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. |
| Q46846346 | Pharmacogenetic study of atypical antipsychotic drug response: involvement of the norepinephrine transporter gene. |
| Q57698088 | Possible association between serotonin transporter gene polymorphism and violent suicidal behavior in mood disorders |
| Q102998401 | Pre-training inter-rater reliability of clinical instruments in an international psychosis research project |
| Q35753980 | Prevalence of psychotic disorders in an urban area of France |
| Q57700304 | Relationship between incidence and prevalence in psychotic disorders: An incidence-prevalence-mortality model |
| Q35122505 | Rural-urban variation in incidence of psychosis in France: a prospective epidemiologic study in two contrasted catchment areas |
| Q26821846 | Schizophrenia and other psychotic disorders in Caribbean-born migrants and their descendants in England: systematic review and meta-analysis of incidence rates, 1950-2013 |
| Q61800831 | Schizophrenia risk factors in exceptional achievers: a re-analysis of a 60-year-old database |
| Q99631494 | Schizophrenia: Developmental Variability Interacts with Risk Factors to Cause the Disorder: Nonspecific Variability-Enhancing Factors Combine with Specific Risk Factors to Cause Schizophrenia |
| Q57698054 | Schizotypal dimensions: An intermediate phenotype associated with the COMT high activity allele |
| Q57698109 | Serotonin transporter gene polymorphisms in patients with unipolar or bipolar depression |
| Q39758969 | Small area-level variation in the incidence of psychotic disorders in an urban area in France: an ecological study |
| Q47673573 | Sociodemographic and clinical correlates of psychotic symptoms in the general population: Findings from the MHGP survey |
| Q36910806 | Spatial distribution of psychotic disorders in an urban area of France: an ecological study |
| Q60050906 | Subclinical psychosis in adult migrants and ethnic minorities: systematic review and meta-analysis |
| Q55004827 | T103. ODIP (OUTIL DE DIAGNOSTIC INFORMATISé DES PSYCHOSES / PSYCHOSIS COMPUTERIZED DIAGNOSTIC TOOL): A NEW, SIMPLE METHOD FOR GENERATING DSM DIAGNOSES FOR PSYCHOTIC DISORDERS. |
| Q55052946 | T114. SCHIZOTYPAL PERSONALITY QUESTIONNAIRE-BRIEF: FACTOR STRUCTURE ANALYSIS IN A NONCLINICAL ROMANIAN SAMPLE. |
| Q54993048 | T132. ASSESSMENT OF CROSS-NATIONAL EQUIVALENCE OF THE COMMUNITY ASSESSMENT OF PSYCHIC EXPERIENCES (CAPE). |
| Q55030973 | T133. MENTAL HEALTH OF ASYLUM SEEKERS AT THE HUMANITARIAN CAMP IN PARIS. |
| Q44290793 | Temperament in schizophrenia: a study of the tridimensional personality questionnaire (TPQ). |
| Q38414048 | Tests of executive functions in first-degree relatives of schizophrenic patients: a meta-analysis |
| Q38669166 | The small G protein RAS2 is involved in the metabolic compensation of the circadian clock in the circadian model Neurospora crassa. |
| Q57031593 | Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study |
| Q47566854 | Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study. |
| Q60435295 | Universal prevention of schizophrenia and surrogate endpoints at population level |
| Q57700315 | WAIS-IV Seven-Subtest Short Form: Validity and Clinical Use in Schizophrenia |
| Q51037053 | [Source monitoring: general presentation and review of literature in schizophrenia]. |